N-Hydroxy - 4-{5-[4-(5-isoproyl-2-methyl-1,3-thiazol4-yl)phenoxy] pentoxy} benzamidine 2 methansulfonic acid salt

Details for Australian Patent Application No. 2005300239 (hide)

International Classifications

Event Publications

6 July 2006 Application Open to Public Inspection

Published as AU-B-2005300239

6 July 2006 PCT application entered the National Phase

PCT publication WO2006/057501 Priority application(s): WO2006/057501

6 August 2009 Application Accepted

Published as AU-B-2005300239

3 September 2009 Amendment Made

The nature of the amendment is: Amend the applicant name to Dong Wha Pharmaceutical Co., Ltd. 2006

3 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.